GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 35.77 | 30.89 | 23.51 | 30.67 | 32.80 |
What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 35.77 |
| Mar2024 | 30.89 |
| Mar2023 | 23.51 |
| Mar2022 | 30.67 |
| Mar2021 | 32.80 |
How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 35.77 | 15.80 | |
| Mar2024 | 30.89 | 31.39 | |
| Mar2023 | 23.51 | -23.35 | |
| Mar2022 | 30.67 | -6.49 | |
| Mar2021 | 32.8 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,744.7 Cr | -2.5% | 1.1% | 8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -2.5% |
1.1% |
8.6% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses